Pharmacosmos to initiate large-scale clinical study programme in support of Monofer® US FDA approval
Holbæk, Denmark, 19 August 2016 – Pharmacosmos announces initiation of a novel study programme to obtain FDA approval of Monofer® while continuing its search for a partner to commercialise Monofer® in the US. The study programme consists of two large-scale US trials in patients